Detailed Information

Cited 11 time in webofscience Cited 17 time in scopus
Metadata Downloads

In vitro antiviral activity of ribavirin against severe fever with thrombocytopenia syndrome virus

Full metadata record
DC Field Value Language
dc.contributor.authorLee, Myung Jin-
dc.contributor.authorKim, Kye-Hyung-
dc.contributor.authorYi, Jongyoun-
dc.contributor.authorChoi, Su Jin-
dc.contributor.authorChoe, Pyoeng Gyun-
dc.contributor.authorPark, Wan Beom-
dc.contributor.authorKim, Nam Joong-
dc.contributor.authorOh, Myoung-don-
dc.date.available2020-02-27T18:41:10Z-
dc.date.created2020-02-06-
dc.date.issued2017-07-
dc.identifier.issn1226-3303-
dc.identifier.urihttps://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5949-
dc.description.abstractBackground/Aims: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by severe fever with thrombocytopenia syndrome virus (SFTSV), a novel bunyavirus. As yet, there is no effective antiviral therapy for SFTS. Ribavirin is a broad-spectrum antiviral agent, which has been tried for treatment of SFTS. In this study, antiviral activity of ribavirin against SFTSV has been investigated. Methods: Vero cell-grown SFTSV strain Gangwon/Korea/2012 was treated with ribavirin at various concentrations. Antiviral activity of ribavirin was evaluated by inhibition of the SFTSV cytopathic effect in Vero cells and quantification of viral RNA load in culture supernatant using one-step real-time reverse transcription polymerase chain reaction. Cytotoxicity of ribavirin was determined by a tetrazolium-based colorimetric method. Results: Ribavirin reduced SFTSV titers in a dose-dependent manner, with a half-maximal inhibitory concentration ranged from 3.69 to 8.72 mu g/mL. Cytopathic effects were reduced as ribavirin concentration increased. No significant cytotoxicity was detected at ribavirin concentrations of <= 31.3 mu g/mL. Conclusions: Ribavirin exhibited inhibitory activity against SFTSV replication in vitro, which suggests that ribavirin can be used as a potential antiviral agent for SFTS.-
dc.language영어-
dc.language.isoen-
dc.publisherKOREAN ASSOC INTERNAL MEDICINE-
dc.relation.isPartOfKOREAN JOURNAL OF INTERNAL MEDICINE-
dc.subjectCONGO HEMORRHAGIC-FEVER-
dc.subjectPATHOGENESIS-
dc.subjectBUNYAVIRUS-
dc.subjectINFECTION-
dc.subjectTHERAPY-
dc.subjectCHINA-
dc.subjectASSAY-
dc.titleIn vitro antiviral activity of ribavirin against severe fever with thrombocytopenia syndrome virus-
dc.typeArticle-
dc.type.rimsART-
dc.description.journalClass1-
dc.identifier.wosid000405512900018-
dc.identifier.doi10.3904/kjim.2016.109-
dc.identifier.bibliographicCitationKOREAN JOURNAL OF INTERNAL MEDICINE, v.32, no.4, pp.731 - 737-
dc.identifier.kciidART002240950-
dc.identifier.scopusid2-s2.0-85025151605-
dc.citation.endPage737-
dc.citation.startPage731-
dc.citation.titleKOREAN JOURNAL OF INTERNAL MEDICINE-
dc.citation.volume32-
dc.citation.number4-
dc.contributor.affiliatedAuthorLee, Myung Jin-
dc.type.docTypeArticle-
dc.subject.keywordAuthorBunyaviridae infections-
dc.subject.keywordAuthorPhlebovirus-
dc.subject.keywordAuthorRibavirin-
dc.subject.keywordAuthorAntiviral agents-
dc.subject.keywordPlusCONGO HEMORRHAGIC-FEVER-
dc.subject.keywordPlusPATHOGENESIS-
dc.subject.keywordPlusBUNYAVIRUS-
dc.subject.keywordPlusINFECTION-
dc.subject.keywordPlusTHERAPY-
dc.subject.keywordPlusCHINA-
dc.subject.keywordPlusASSAY-
dc.relation.journalResearchAreaGeneral & Internal Medicine-
dc.relation.journalWebOfScienceCategoryMedicine, General & Internal-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
Files in This Item
There are no files associated with this item.
Appears in
Collections
ETC > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE